Elkfork Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $20.2M | Buy |
119,308
+36,596
| +44% | +$6.2M | 0.49% | 50 |
|
|
2019
Q2 | $15.2M | Sell |
82,712
-7,252
| -8% | -$1.33M | 0.37% | 62 |
|
|
2019
Q1 | $16.5M | Buy |
89,964
+1,708
| +2% | +$314K | 0.42% | 60 |
|
|
2018
Q4 | $14.6M | Sell |
88,256
-3,696
| -4% | -$612K | 0.41% | 56 |
|
|
2018
Q3 | $17.7M | Sell |
91,952
-5,572
| -6% | -$1.07M | 0.42% | 60 |
|
|
2018
Q2 | $16.6M | Sell |
97,524
-868
| -0.9% | -$148K | 0.43% | 58 |
|
|
2018
Q1 | $16M | Buy |
98,392
+44,940
| +84% | +$7.32M | 0.43% | 56 |
|
|
2017
Q4 | $8.01M | Sell |
53,452
-1,484
| -3% | -$222K | 0.22% | 96 |
|
|
2017
Q3 | $8.35M | Sell |
54,936
-19,236
| -26% | -$2.92M | 0.24% | 84 |
|
|
2017
Q2 | $9.56M | Sell |
74,172
-3,080
| -4% | -$397K | 0.29% | 71 |
|
|
2017
Q1 | $8.45M | Sell |
77,252
-7,644
| -9% | -$836K | 0.26% | 75 |
|
|
2016
Q4 | $6.25M | Buy |
+84,896
| New | +$6.25M | 0.21% | 90 |
|